Appendix 3C - Notification of buy-back Announcement Summary Name of entity CYNATA THERAPEUTICS LIMITED Announcement type New announcement Date of this announcement 20/10/2026 ASX Security code and description of the class of +securities the subject of the buy-back CYP : ORDINARY FULLY PAID The type...
Notification of buy-back - CYP
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Letter to Ineligible Shareholders-Entitlement Offer
- Letter to Eligible Shareholders-Entitlement Offer
- Replacement Target Market Determination
- Replacement Prospectus
- Target Market Determination
Later from Cynata Therapeutics
- Unmarketable Parcel Sale Facility
- Paul Wotton to Resign as Director from AGM
- Letter to Shareholders, Notice of AGM & Proxy Form
- September 2026 Quarterly Activity Report & Appendix 4C
- Results of Fully Underwritten Entitlement Offer
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics